NasdaqGM:IRONBiotechs
Disc Medicine (IRON) Could Be 67% Undervalued On Its $30 Million Loan Reset
Disc Medicine (IRON) amended its loan agreement with Hercules Capital, drawing US$30 million immediately and extending access to multiple future tranches. This financing move could influence how investors view its cash runway and clinical plans.
See our latest analysis for Disc Medicine.
Disc Medicine's latest debt amendment comes after a period where short term share price momentum has been positive, with a 90 day share price return of 14.99%. However, the year to date share price return has...